| Date | Type | Memo |
|---|---|---|
| 12-02-2009 : | SEE REPLACEMENT PHARMACEUTICAL CONTRACT 09009, EFFECTIVE JANUARY 1, 2010. TRANSITION PERIOD For MMCAP members currently using Cardinal that will be continuing with Cardinal, the transition to the terms of the new agreement will occur on 1/1/2010. For MMCAP members that are currently using another MMCAP-contracted PPV that have selected Cardinal as their new PPV, the transition to Cardinal will occur no later than 3/1/2010. A representative from Cardinal will be contacting you shortly to begin the transition process. TRAINING SESSIONS MMCAP will be scheduling new agreement training sessions in the next few weeks to acquaint you with the new Cardinal agreement and to answer your questions. The new agreement has been posted on MMCAP’s website so that you can review it prior to the training sessions. If you have any questions that require answers prior to the training sessions, please contact Almena Dees at 651-201-3046 or almena.dees@state.mn.us. | |
| 12-02-2009 : | The new Cardinal rebid contract will be signed by 11/30 or 12/1. Unlike all the other contracts, the Cardinal contract will go into effect on January 1, 2010. However, the other PPVs don’t have a start date at this time. | |
| 11-13-2009 : | MMCAP updates the membership every month through their newsletter and state conference calls and have updated the Advisory Board every month. MMCAP had three calls specifically with the states that choose AmerisourceBergen as the negotiations and agreement language were progressing slower than the other prime vendors. Regarding Cardinal, we are finishing a few agreement clauses that both sides have been red-lining and anticipate the agreement signing by November 30 which means states that are currently utilizing Cardinal would transition to the new agreement no later than January 1, 2010. | |
| 10-08-2009 : | MMCAP is waiting to release the vendor awards. For additional information on the prime vendor selection outcome please visit the MMCAP website: www.mmcap.org. | |
| 09-02-2009 : | MMCAP is completing the final vendor/wholesaler negotiations. Expected award anticipated November/Dec 2009 timeframe. Current contract remains still good until the end of the year, December 31, 2009. | |
| 08-14-2009 : | MMCAP has extended the negotiations period for the selected Prime Vendors in an effort to provide the very best pricing discounts for all Participating States concerned. MMCAP advised the Participating States negotiations should run through September 2009. | |
| 07-01-2009 : | Because of the concurrent generic product contract roll, an overwhelming number of requests from our membership to provide adequate time for a smooth transition for Participating States that MAY be making a wholesaler change, and additional time for MMCAP to perform through negotiations, MMCAP has received internal approval to process contract extensions of all Prime Vendor contracts (AmerisourceBergen, Cardinal Health, and Morris & Dickson). The contracts are extended from 6/30/09 to 12/30/09. While we left an extra buffer in the event of any snags, it is our intent to have all contracts executed by September 1, 2009 with a transition period of up to 3 months. | |
| 06-17-2009 : | MMCAP will extend the pharmaceutical contract through the end of the year, 12/31/09 | |
| 06-01-2009 : | Nevertheless, a pharmaceutical contract has been sucessfully negotiated with MMCAP that will become effective January 1, 2010. Participating Facilities for Washington State have access to the MMCAP Website and may get additional specifics pertaining to both contract negotiations and awards. | |
| 06-01-2009 : | Washington State's Prime Vendor Selection was completed successfully. We are currently awaiting the green light from MMCAP to notify all Participating State Agencies of the final selections. | |
| 05-07-2009 : | MMCAP notified all Participating States the current Pharmaceutical contract with Cardinal Medical will be extended through December 31,2009 to allow for a smooth transition into the new contract award. | |
| 05-04-2009 : | MMCAP anticipates the release of Best and Final (BAFO) results for Pharmaceutical Prime Vendor Selections the week of May 8, 2009. | |
| 04-08-2009 : | Attended the 2009 MMCAP Annual Meeting in Minnesota March 31- April 2, 2009. The conference offered additional insite on the Prime Vendor Selection process and offered all participating states an opportunity to engage in the pharmaceutical awards ceremony. | |
| 04-08-2009 : | Prime Vendor Selection process is well underway for the State of Washington. Both potential bidders; AmerisourceBergen and Cardinal Health were interviewed on March 24, 2009 by the Washington State Stakeholder Committee. The committee was represented by the followign State Agencies: DSHS, DOC and King County Jail. The PPV Committee for Washington have completed the initial phase of the evaluation and scoring for both vendors. However - MMCAP has decided to proceed with final negotiations to get the best overall price/value bidding outcome. MMCAP will have an outcome to final negotations in approximately 3 weeks (end of April). The current pharmaceutical contract with Cardinal Health will expire on June 30, 2009. - Washinton State will embark on a final evaluation/scoring to address the final negotiation process managed by MMCAP. | |
| 03-23-2009 : | Prime Vendor interviews have been scheduled for March 24, 2009. The following agencies will participate in the interview process: DOC, DSHS, King County with OSP as the facilator. | |
| 03-23-2009 : | Washington State has formed its Prime Vendor Committee to meet and interview both Cardinal and AmerisourceBergen pharmaceutical vendors. | |
| 01-07-2009 : | GA food programs is interested in participating on the MMCAP Pharmaceutical contract to support their varied food banks operations etc; with infant formula as well as adult nutrirtionals like boost and ensure suppliments, to be purchased via the MMCAP contract 01804, Joe Bippert heading up this effort and was sent an MMCAP new facility application to sign-up. | |
| 09-10-2008 : | Posted on Aug 29, 2008 - MMCAP Rabies Vaccine Shortage Update. There has been a reduced national rabies vaccine supply over the past several months. Beginning August 29, 2008, Sanofi Pasteur in coordination with the Centers for Disease Control and Prevention (CDC) will resume shipping IMOVAX® Rabies, Rabies Vaccine for post-exposure prophylaxis only. Customers should call 1-800-VACCINE (1-800-822-2463) if interested in ordering. A Rabies Post-Exposure Form will need to be completed and faxed to the number on the form. RabAvert rabies vaccine from Novartis Vaccines is available for post-exposure prophylaxis only. To ensure adequate risk assessments at the local level, MMCAP members will be required to obtain a confirmation code from state or local health departments before ordering RabAvert from Novartis Vaccines. At the request of the CDC, a small portion of the rabies vaccine supply has been reserved for high priority pre-exposure, which will be managed by the CDC. For additional information regarding the rabies vaccine supply situation, please visit the CDC's website at: http://www.cdc.gov/rabies/ | |
| 08-07-2008 : | Andre Rossi has expressed concerns about the tiered discounts offered by Cardinal. DOC is currently only being offered a base discount. Sara Turnbow looking into the matter to confirm what DOC's appropriate tier level should be. | |
| 02-05-2008 : | The special offer on Gardasil detailed below has been extended through February 29, 2008. Please remember that this discount applies to direct purchases from Merck Vaccine only (you will not get contract pricing through your MMCAP-contracted wholesaler). In honor of National Cervical Cancer Month, Merck Vaccine is offering a special limited-time special on direct purchases of Gardasil (Human Papillomavirus Quadrivalent [Types 6, 11, 16, and 18] Vaccine). MMCAP members must purchase a minimum of 70 doses of Gardasil in a single order per shipping location directly from Merck Vaccine between January 1, 2008 and February 15, 2008 to qualify for a 2% discount on those doses. Customers cannot combine packaging configurations (e.g., packaging containing 1 single dose 0.5-mL vial, 10 single dose 0.5 mL-vials, and 6 single dose 0.5-mL syringes) to meet the 70 dose minimum. Merck Vaccine's payment terms are 2% 90 net 91, meaning that an additional 2% discount is available if the invoice is paid within 90 days or less. Orders can be placed by calling Merck Vaccine directly at 1-800-MERCK-90 (1-800-637-2590), Monday through Friday, 8:00 AM–7:00 PM, EST or online at www.merckvaccines.com. Please note, this is for orders placed directly with Merck Vaccine, not through your MMCAP-contracted wholesaler. | |
| 02-26-2007 : | Update current contract information to reflect Office of State Procurement's Contract's Specialist and Office Assistant. | |
| 03-29-2006 : | Total volume for purchases from MMCAP member participating with Cardinal as their Pharmaceutical distributor has surpassed the $900 million mark. Therefore an additional .35% can be added to the negative upcharge. The monthly volume for participating Washington MMCAP member is $1.5 million to $3 million. | |
| 02-10-2006 : | Contract 01804 will be extended pending additional information from MMCAP. It is anticipated that the extension will be completed by the first of March, 2006. Customers are encourage to submit CPE's and/or concerns or issues at any time to Sheila Mott via email, phone (360-902-7438) or other. | |
| 01-19-2006 : | Contract 01804 is due to expire April 30, 2006 and is currently being reviewed for extension. It is anticipated that the extension will be completed by the first of March, 2006. Contractor Performance Evaluations should be submitted to Sheila Mott, Contract Specialist, at smott@ga.wa.gov or 360-902-7438 by February 24, 2006. | |
| 12-05-2005 : | Contract 01804 is due to expire April 30, 2006 and is currently being review for possible extension. It is anticipated that a final decision will be completed by March 1, 2006. | |
| 12-05-2005 : | The annual MMCAP Conference is scheduled for January 31, 2006 through February 3rd. Two representatives (one purchasing/one pharmacy) from the State of Washington attend every year. The representatives are appointed by the Assistant Director of Procurement. Guy Kuestermeyer, Pharmacy Director for Rainier School has been participating for about 11 years and Sheila Mott from the Office of State Procurement has been participating at the conference for six years. Washington MCCAP member should direct any questions or concern to Sheila Mott (smott@ga.wa.gov or 360-902-7438). | |
| 11-17-2005 : | Contract is due to expire April 30, 2006. Contractor Performance Evaluation will be issued by the end of November and the contract will be review for possible extension. It is anticipated that the final decision will be completed by March 1, 2006. | |
| 10-10-2005 : | In anticipation of the upcoming MMCAP Pharmaceutical RFP and the awards made at the annual meeting, MMCAP is compiling a list of specific needs for MMCAP participants areas of practice. This list will be used to streamline the awards and later review. Examples are: Family awards for generic antipsychotics; Dual awards for seizure, heart, and blood thinning medications; No glass or metal for correctional facilities (although the proposals do not specifically indicate packaging type, some of the members making the award may know the product’s package type). Please send your specific practice needs by October 14. Responses are to be directed to Sheila Mott, smott@ga.wa.gov or phone 360-902-7438. | |
| 12-10-2004 : | Discount Program Enrollment Agreements are available for Symbyax and Zyprexa. The MMCAP web site: http://www.mmd.admin.state.mn.us/mmcap/member_pharm.htm , includes Reduced Pricing Opportunities. Eligible facilities can access these discount forms by contacting the state MMCAP contact, Sheila Mott at smott@ga.wa.gov or 360-902-7438. | |
| 09-03-2004 : | MMCAP has entered into a market share agreement with Barr Laboratories to provide University Student Health Facilities with reduced pricing on oral contraceptives. These products will be available beginning 8/16/04 from MMCAP's distributor for Washington, Cardinal Health. More information is available on the MMCAP Website:http://www.mmd.admin.state.mn.us/mmcap/nm/publish/news_59.html | |
| 04-28-2004 : | The new contract for Pharmaceutical Products Distributor has been completed and is available online. | |
| 04-08-2004 : | New MMCAP Contract 01804 for Pharmaceutical Products Distributor will be released soon, effective May 1, 2004 for an initial 2-year period. Contract will be a Mandatory use contract available to all participating MMCAP members. The awarded Contractor is Cardinal Health. |
The Contracts Resource Center is here to help.